Prevalence of ovarian cancer cachexia in patients undergoing cytoreductive surgery at the University of Colorado between 2014-2024 [0.03%]
2014年至2024年间科罗拉多大学接受细胞减灭术的卵巢癌恶病质患者患病率
Eseohi Ehimiaghe,Andrew Nicklawsky,Stephanie Wang et al.
Eseohi Ehimiaghe et al.
The role of small extracellular vesicles in ovarian cancer drug resistance: from bench clues to clinical implications [0.03%]
卵巢癌耐药中微小细胞外囊泡的作用：从实验线索到临床意义
Junhao Chen,Zheng Gu,Keqin Hua et al.
Junhao Chen et al.
Reza Mohammadpour Fard,Mohadese Nadi,Zahra Mansouri et al.
Reza Mohammadpour Fard et al.
Dual TP53 mutations in ovarian high-grade serous carcinoma combined with squamous cell carcinoma: a case report and systematic literature review [0.03%]
卵巢高级别浆液性癌合并鳞状细胞癌中TP53基因双重突变一例及文献系统复习
Chao-Lian Li,Jie-Ping Lu,Qiu-Xing Lan et al.
Chao-Lian Li et al.
Objective: This study reports a rare case of mixed ovarian carcinoma composed of squamous cell carcinoma (SCC) and high-grade serous carcinoma (HGSC) arising from endometriosis, and provides a systematic review of the rel...
Identification of ovarian cancer-associated antigens forming complexes with autoantibodies [0.03%]
与自身抗体结合的卵巢癌相关抗原的鉴定
Mimori Fujimori,Kai Uryu,Makoto Kobayashi et al.
Mimori Fujimori et al.
Impact of oral contraceptive treatment duration on ovarian reserve markers and pain in women with ovarian endometrioma: a retrospective cohort study [0.03%]
口服避孕药治疗持续时间对卵巢子宫内膜异位囊肿患者卵巢储备标志物和疼痛的影响：回顾性队列研究
Gökçenur Karakelleoğlu,Cihan Karadağ,Levent Çelik
Gökçenur Karakelleoğlu
Interconnected cell death pathways: central mechanisms and therapeutic targets in impaired follicular development of polycystic ovary syndrome [0.03%]
相互关联的细胞死亡通路在多囊卵巢综合症受损卵泡发育中的中心机制和治疗靶点
Shuang Ma,Chang Sun,Yasong Wang et al.
Shuang Ma et al.
CC223 enhances cisplatin sensitivity of platinum-resistant ovarian cancer by inducing cell cycle arrest [0.03%]
CC223通过诱导细胞周期阻滞增强顺铂对铂耐药卵巢癌的敏感性
Ling Wang,Haixai Wang,Xueping Zhu et al.
Ling Wang et al.
An explainable machine learning model for identifying the risk of suboptimal oocyte maturation in patients with polycystic ovary syndrome undergoing GnRH-antagonist protocol [0.03%]
一种解释性的机器学习模型：用于识别多囊卵巢综合征患者在使用GnRH拮抗剂方案中卵子发育不良风险的模型
Longying Zhao,Guoqing Fan,Wanxin Wang et al.
Longying Zhao et al.